Document Detail


Targeting Fas/FasL signaling, a new strategy for maintaining bone health.
MedLine Citation:
PMID:  21736533     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The treatment of osteoporosis has been a critical issue in today's medical situation. Various therapeutic agents and strategies have been investigated and applied, and have proven successful in the treatment of osteoporosis. However, some concerns still remain, such as the adverse effects of such treatments. From this point of view, a search for novel therapeutic targets, such as Fas signaling, remains important.
Authors:
Yuuki Imai; Alexander Kouzmenko; Shigeaki Kato
Related Documents :
9223703 - Changing status of academic emergency medicine (1991-1996). task force on the developme...
8399043 - A survey of british medical schools policies with regard to applications from dental gr...
24509103 - Willingness to participate in a clinical trial and understanding of informed consent in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-8
Journal Detail:
Title:  Expert opinion on therapeutic targets     Volume:  -     ISSN:  1744-7631     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101127833     Medline TA:  Expert Opin Ther Targets     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
The University of Tokyo , Institute of Molecular and Cellular Biosciences, Tokyo , Japan uskato@mail.ecc.u-tokyo.ac.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Helicobacter pylori cagA polymorphism and gastric inflammation: An international comparison between ...
Next Document:  Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism.